Arabesque Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-15,556
Closed -$4.09M 9
2022
Q4
$4.09M Buy
15,556
+4,547
+41% +$1.22M 1.38% 15
2022
Q3
$2.48M Buy
+11,009
New +$2.67M 1.21% 13
2022
Q2
Sell
-6,865
Closed -$1.66M 121
2022
Q1
$1.66M Buy
+6,865
New +$1.58M 0.58% 90
2020
Q3
Sell
-853
Closed -$201K 67
2020
Q2
$201K Buy
+853
New +$195K 0.14% 79

Other funds holding AMGN

Arabesque Asset Management's AMGN Position: Q1 2023 in Review

Arabesque Asset Management sold out of Amgen (AMGN) in Q1 2023, closing a stake of 15,556 shares — an estimated $4.09M sold.

Arabesque Asset Management first reported a position in AMGN in Q2 2020 and held it in 4 quarters. The position peaked at $4.09M in Q4 2022. 2,435 funds tracked by Wall St. Rank hold AMGN as of Q1 2023.

  • Arabesque Asset Management reported no remaining Amgen position as of Q1 2023 after selling out during the quarter.
  • Arabesque Asset Management sold 15,556 Amgen shares in Q1 2023, an estimated $4.09M.
  • Arabesque Asset Management first reported a position in Amgen in Q2 2020 and held it in 4 quarters.
  • Arabesque Asset Management's Amgen position peaked at $4.09M in Q4 2022.
  • 2,435 funds tracked by Wall St. Rank held Amgen as of Q1 2023.

Based on Arabesque Asset Management's 13F filing for Q1 2023.